Traditional PK-PD Indices for Efficacy – Can We Do Better?

Por Lakota, Elizabeth A, Bader, Justin C, Bhavnani, Sujata M, Andes, David R, Ambrose, Paul G
Publicado no Open Forum Infect Dis (2017)

At the Crossroads of Stewardship and Technology: Impact of Pharmacokinetic-Pharmacodynamic (PK-PD) Integrated Electronic Decision Support Software (EDSS) on the Treatment of Patien...

Por Bader, Justin C, Bulik, Catharine C, Bhavnani, Sujata M, Rubino, Christopher M, Sweeney, Kim L, Ambrose, Paul G, Owens, Robert C
Publicado no Open Forum Infect Dis (2017)

Getting it Right the First Time: Relating Pharmacokinetic-Pharmacodynamic Target Attainment and Patient Outcomes

Por Bulik, Catharine C, Bader, Justin C, Lakota, Elizabeth A, Bhavnani, Sujata M, Rubino, Christopher M, Sweeney, Kim L, Ambrose, Paul G, Owens, Robert C
Publicado no Open Forum Infect Dis (2017)

Pharmacological Basis of CD101 Efficacy: Exposure Shape Matters

Por Lakota, Elizabeth A., Bader, Justin C., Ong, Voon, Bartizal, Ken, Miesel, Lynn, Andes, David R., Bhavnani, Sujata M., Rubino, Christopher M., Ambrose, Paul G., Lepak, Alexander J.
Publicado no Antimicrob Agents Chemother (2017)

Generation of Immunity against Pathogens via Single-Domain Antibody–Antigen Constructs

Por Duarte, Joao N., Cragnolini, Juan J., Swee, Lee Kim, Bilate, Angelina M., Bader, Justin, Ingram, Jessica R., Rashidfarrokhi, Ali, Fang, Tao, Schiepers, Ariën, Hanke, Leo, Ploegh, Hidde L.
Publicado no J Immunol (2016)

Transposon Mutagenesis Screen Identifies Potential Lung Cancer Drivers and CUL3 as a Tumor Suppressor

Por Dorr, Casey, Janik, Callie, Weg, Madison, Been, Raha A., Bader, Justin, Kang, Ryan, Ng, Brandon, Foran, Lindsey, Landman, Sean R., O’Sullivan, M. Gerard, Steinbach, Michael, Sarver, Aaron L., Silverstein, Kevin A. T., Largaespada, David A., Starr, Timothy K.
Publicado no Mol Cancer Res (2015)